首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Cefazolin and moxalactam pharmacokinetics after simultaneous intravenous infusion.
【2h】

Cefazolin and moxalactam pharmacokinetics after simultaneous intravenous infusion.

机译:同时静脉输注后头孢唑林和莫拉西坦的药代动力学。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A high-performance liquid chromatographic method for the measurement of moxalactam concentrations in serum was modified to permit the simultaneous measurement of both moxalactam and cefazolin. We then studied whether the simultaneous administration of both moxalactam and cefazolin to normal subjects would produce profiles of serum concentration versus time which were the same as those obtained after the administration of each drug individually. Six healthy adults received a 30-min infusion of cefazolin (10 mg/kg), followed in 2 days by the same dose of moxalactam. After 2 days, both antibiotics were administered together. A two-compartment model was found to adequately characterize the data, and the serum concentration curve for each drug when given alone was statistically identical to that obtained after simultaneous administration. Cefazolin was found to produce a significantly greater peak serum concentration (105 +/- 14 versus 81 +/- 21 microgram/ml) and a significantly greater area under the curve (218 +/- 42 versus 157 +/- 19 . microgram h/ml). The terminal half-life of moxalactam was not significantly longer than for cefazolin (2.2 +/- 0.6 versus 2.0 +/- 0.6 h, respectively). The method of simultaneous administration may have distinct advantages over conventional methods for studies of comparative tissue penetration.
机译:改进了一种用于测定血清中莫拉西坦浓度的高效液相色谱方法,以允许同时测量莫拉西坦和头孢唑林。然后,我们研究了同时向正常受试者同时服用莫西内酰胺和头孢唑林是否会产生血清浓度随时间变化的曲线,该曲线与单独给药每种药物后获得的曲线相同。六名健康成年人接受了30分钟的头孢唑林(10 mg / kg)输注,然后在2天内注射了相同剂量的莫拉西坦。 2天后,将两种抗生素一起施用。发现两室模型足以表征数据,并且当单独给药时每种药物的血清浓度曲线在统计学上与同时给药后获得的相同。发现头孢唑啉产生的峰值血药浓度明显更高(105 +/- 14对81 +/- 21微克/毫升),曲线下面积明显更大(218 +/- 42对157 +/- 19微克/毫升)。 / ml)。莫拉西坦的终末半衰期并不比头孢唑林长(分别为2.2 +/- 0.6和2.0 +/- 0.6 h)。与常规方法相比,同时给药的方法相对于组织穿透性的研究可能具有明显的优势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号